August 2026 · 10 min read · Clinical Protocol
What Spinal Fusion Is, and Why Some Fusions Fail
Spinal fusion (arthrodesis) joins two or more adjacent vertebrae with a bone graft so that they heal into one continuous segment. It is performed for instability with stenosis, spondylolisthesis, scoliosis and advanced degenerative disease. Success is not judged in theatre — it is judged at 9 to 12 months, when imaging shows a continuous bony bridge.
The common failure is pseudarthrosis: a fusion that never completes. A review of 82 published studies cited by Mooney (PubMed 25951594) found fusion success ranging from 16% to 93%, mean 66%. The risk factors are well established: smoking (a reported 32% decrease in fusion healing), allograft instead of autograft, and the number of levels fused — each additional level lowers the probability of success by roughly 20%.
What the Randomized Evidence Shows
This is the highest grade of evidence anywhere in the PEMF literature — meta-analyses of randomized controlled trials, not case series.
- 2024 meta-analysis (PubMed 39278993, Luo et al., Neurosurgical Review): post-operative electrical stimulation raised the odds of successful fusion — OR 2.66 (95% CI 1.79–3.97), mean fusion rate 86.8% vs 73.7%. The PEMF-only subgroup: OR 2.60 (95% CI 1.29–5.27).
- 2020 meta-analysis (PubMed 32165697 · PMC7067864, Akhter et al., Scientific Reports): 7 randomized trials, n=941 (487 stimulation, 454 control). OR 2.53 (95% CI 1.86–3.43, p<0.00001), moderate-quality evidence, therapeutic level I.
- The large double-blind trial (PubMed 2218718, Mooney, Spine 1990): n=195 undergoing interbody lumbar fusion, 98 active and 97 sham brace. 92% success in the active group vs 65% in placebo. This is the trial the FDA indication was built on.
- FDA-cleared device review (Bioelectromagnetics 2018, PMC5822965): cervical fusion rate 83% vs 65% in control.
One qualification belongs here rather than in a footnote: both meta-analyses pooled three different stimulation technologies — PEMF, implanted direct current, and capacitive coupling. In the 2020 analysis the subgroup interaction by stimulation type was not significant (p=0.93), meaning there is no evidence one is superior, but also no clean separation. The PEMF-specific estimate is the 2024 one, and its confidence interval is wider.
Where It Works — and Where a Trial Found Nothing
The benefit concentrates in high-risk and non-instrumented fusions. Where mechanical fixation already delivers a high fusion rate, the randomized trial found no difference. This is the most useful clinical distinction on this page.
The negative trial (PubMed 10941887, Jenis et al., 2000): a prospective randomized study, n=61, three arms — PEMF (n=22), implanted direct current (n=17) and control (n=22), all after instrumented posterolateral lumbar fusion. At one year there was no significant difference in fusion rate or in fusion-mass bone mineral density. The authors' conclusion: electrical stimulation does not significantly enhance fusion in instrumented lumbar arthrodesis.
The trial showing where it does work (PubMed 12131732, Linovitz et al., Spine 2002): a 10-site double-blind placebo-controlled trial, 243 enrolled and 201 evaluable, in primary non-instrumented posterolateral lumbar fusion — 30 minutes daily for 9 months. 64% fusion vs 43% placebo (p=0.003). And the finding that demands care: the effect was significant in women (67% vs 35%, p=0.001) and not statistically significant in the male study population. No later trial has explained that difference. Note also that the modality here was combined magnetic fields, not classic PEMF.
On smoking: long-term follow-up of the same 195 patients (PubMed 10549700) found a roughly 25% reduction in maintenance of the fusion over time — unrelated to treatment group, and statistically correlated with smoking. No electromagnetic stimulation offsets that risk factor.
How the Field Acts on Bone at the Fusion Site
A changing magnetic field induces an electrical potential in tissue, and that potential is a biological signal bone already uses in its own repair. An external coil generates a pulsing magnetic field around the fusion site; by the law of induction, a changing magnetic field induces an electric field in conductive tissue. The result is an electronegative potential at the site, similar to the potentials measured naturally around a healing fracture.
The technology is neither new nor experimental: it was established first in long-bone non-unions and extended from there to the spine. The shared principle is that stimulation does not create bone from nothing — it accelerates and reinforces a process already under way. Graft quality, fixation stability and smoking cessation remain the dominant variables, with stimulation layered above them.
Clinical Protocol and Post-Operative Role
The protocol is set by the operating surgeon, and treatment begins only with written clearance. In the dedicated-stimulator literature the striking parameter is cumulative daily exposure — 30 minutes per day for 9 months in the posterolateral trial, and at least 2 hours per day for 90 days in the pseudarthrosis salvage series (PubMed 14763594, n=100, 67% fusion — an uncontrolled case series). Adherence, not device power, is the critical variable.
- Written surgeon clearance — start date, permitted positions, fixation status.
- Contraindication screening — pacemaker or any active electronic implant, pregnancy, malignancy in the treatment area, epilepsy, active bleeding.
- Coil placement over the relevant region, over clothing, never in direct contact with the surgical wound or sutures.
- Frequency — 2–3 clinic sessions weekly in the first phase; a medical-grade home unit allows daily exposure.
- Measurement — VAS, analgesic consumption, range of motion and functional scores every 4 weeks.
- Active rehabilitation continues in full — walking, breathing exercises, graded strengthening. Stimulation replaces none of it.
Stop and seek urgent review for: fever, wound discharge or redness, new escalating pain unlike the surgical pain, progressive leg weakness, saddle numbness, or any change in bladder or bowel control.
Are the Approved Fusion Devices the Same as a Clinical PEMF System?
No — and we would rather say so ourselves. Every study above was run with a dedicated bone-growth stimulator: a wearable device carrying a specific regulatory indication for spinal fusion, worn for hours a day over months. That is a separate device category with its own model, manufacturer and clearance.
Clinical PEMF systems, including the ones we supply, do not belong to that category and carry no spinal fusion indication. Their role after spine surgery is supportive — reducing pain and oedema and supporting rehabilitation — not achieving fusion. Every regulatory clearance, anywhere, belongs to a specific model with a specific indication, never to "PEMF technology" and never to a company. A procurement manager should ask for the certificate for the exact model, with the indication written on it and its expiry date. A spine surgeon resolves this distinction in one click, so it is better found here.
PEMF vs. Other Fusion-Support Options
| Parameter | Electromagnetic (PEMF) | Implanted direct current | Active rehabilitation only |
|---|---|---|---|
| Evidence level in spinal fusion | Meta-analyses of RCTs, level I | Meta-analyses of RCTs, level I | Standard of care — the control arm |
| Reported effect size | OR 2.60 (1.29–5.27) | OR 2.33 (1.37–3.96) | Baseline fusion rate 73.7% |
| Invasiveness | None — fully external | Surgical — implanted during the procedure | None |
| In instrumented fusion | No significant difference (n=61) | No significant difference (n=61) | Already a high fusion rate |
| Patient sensation | Painless, no current, no undressing | Permanent implant; may require removal | Effort and adherence required |
| Critical success variable | Cumulative exposure hours | Implant placement | Persistence with exercise |
Integrating PEMF After Spine Surgery
One integration note is specific to this patient: spinal manipulation over a fused segment is a contraindication, not a combination. That is precisely why clinics reach for a modality that requires no contact with and no movement of the segment.
- PEMF: reduces deep tissue inflammation and oedema without touching the operated segment
- Guided physiotherapy: walking, breathing work and graded strengthening on the surgeon's timeline
- Smoking cessation: the single largest modifiable determinant of whether the fusion holds
This combined approach is used across Israel's 70+ PainFree clinics serving a population of 9M — now expanding to the Philippines.
Who Can Receive Treatment?
Broad eligibility: chronic pain patients, athletes, elderly patients, children, post-surgical patients, and patients with complex neurological or orthopedic backgrounds. Contraindications are narrow: pacemaker or active electronic implant, pregnancy, active epilepsy, active malignancy in the treatment area, active bleeding. After spine surgery, explicit surgeon clearance is required for both start date and permitted positioning.
What This Means for Clinic Investors
Post-spinal-surgery patients are a segment most clinics decline — not for lack of interest, but because nearly every manual modality is off-limits over the fused segment in the first months. A treatment requiring no contact, no segment movement and no patient effort is one of the few things that can be offered in that window, and it is offered in cooperation with the referring surgeon rather than around them. In the Philippines market, at ₱1,500–₱2,500 per session, that is a referral relationship with spine surgeons rather than a walk-in stream.
Sources
- Luo M et al. Effect of electrical stimulation on the fusion rate after spinal surgery: a systematic review and meta-analysis. Neurosurg Rev 2024 — PubMed 39278993
- Akhter S et al. Efficacy of Electrical Stimulation for Spinal Fusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Sci Rep 2020 — PubMed 32165697 · PMC7067864
- Mooney V. A randomized double-blind prospective study of the efficacy of pulsed electromagnetic fields for interbody lumbar fusions. Spine 1990 — PubMed 2218718
- Mooney V et al. Effects of smoking and maturation on long-term maintenance of lumbar spinal fusion success. J Spinal Disord 1999 — PubMed 10549700
- Linovitz RJ et al. Combined magnetic fields accelerate and increase spine fusion. Spine 2002 — PubMed 12131732
- Jenis LG et al. Prospective comparison of direct current electrical stimulation and pulsed electromagnetic fields on instrumented posterolateral lumbar arthrodesis. J Spinal Disord 2000 — PubMed 10941887 (negative result)
- Simmons JW Jr, Mooney V, Thacker I. Pseudarthrosis after lumbar spine fusion: nonoperative salvage with pulsed electromagnetic fields. Am J Orthop 2004 — PubMed 14763594 (uncontrolled case series)
- Mooney V. Pulsed electromagnetic fields: an adjunct to interbody spinal fusion surgery in the high risk patient. Surg Technol Int 1993 — PubMed 25951594
Request the full investor package.
Request Investment Brief →